Doctorrelief

Description

No specific details regarding the Description section for SPL code 34089-3 are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including arthritis, bruises, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over should begin by cleaning and drying the affected area. After preparing the skin, the healthcare professional should instruct the patient to open the pouch and remove the patch. If necessary, the patch may be cut to the desired size before application. The protective backing should be peeled off, allowing the sticky side of the patch to be applied directly to the affected area. The patch may be applied up to three times daily. It is important for patients to wash their hands with soap after applying the patch to prevent accidental contact with other areas of the body.

For children under 12 years of age, it is recommended that a healthcare professional be consulted prior to use.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

The product is contraindicated for application on ulcerative or suppurative skin areas. It is also not recommended for use during pregnancy due to potential risks to the developing fetus.

Healthcare professionals should be aware that this product may elicit allergic reactions in some individuals. It is intended for external use only, and users must adhere strictly to the following guidelines to ensure safe application:

• The product should be used only as directed.

• Care must be taken to avoid contact with the eyes, mucous membranes, or any rashes.

• It should not be applied to broken, wounded, or damaged skin.

• Bandaging or covering the treated area with any type of wrap, except for clothing, is not advised.

• The use of heating pads or the application of external heat in conjunction with this product is prohibited.

• Users should discontinue application at least one hour prior to bathing or showering and should refrain from using the product immediately after bathing or showering.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Patients should be advised to consult a healthcare provider if symptoms persist for more than seven days, if symptoms resolve and then recur within a few days, or if any of the following occur: rash, itching, excessive skin irritation, or if the condition worsens or fails to improve after regular use. Regular monitoring of the patient's response to treatment is essential to ensure safety and efficacy.

Side Effects

Patients using this product should be aware that it is for external use only and must be applied strictly as directed. Contact with the eyes, mucous membranes, or rashes should be avoided. The product should not be applied to broken, wounded, or damaged skin, nor should it be bandaged or covered with any type of wrap except clothing. Additionally, it should not be used in conjunction with a heating pad or any external heat source. Patients are advised to discontinue use at least one hour before bathing or showering and to avoid application immediately after such activities.

Warnings and precautions indicate that the product should not be applied to ulcerative or suppurative skin areas and is contraindicated during pregnancy. There is a potential for allergic reactions in some individuals, which should be monitored closely.

Patients are encouraged to consult a healthcare professional if symptoms persist for more than seven days, if a rash, itching, or excessive skin irritation develops, or if the condition worsens or does not improve after regular use.

Drug Interactions

This product may induce allergic reactions in certain individuals. Clinicians should be vigilant for signs of hypersensitivity and consider alternative therapies if such reactions occur.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring for interactions with other medications or laboratory tests is not necessary. However, standard clinical judgment should be applied when prescribing this product alongside other therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Doctorrelief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. The safety and efficacy of this medication in this age group have not been established, and appropriate dosing may vary. It is essential for healthcare providers to evaluate the individual needs of pediatric patients when considering treatment options.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The use of this medication is contraindicated in pregnant patients. There is insufficient data to assess the potential risks associated with its use during pregnancy. Healthcare professionals should advise women of childbearing potential to avoid this medication if they are pregnant or plan to become pregnant. The potential for adverse fetal outcomes necessitates careful consideration and counseling regarding the risks involved.

Lactation

Lactating mothers should be aware that this product is not to be used during pregnancy. There is no specific data available regarding the excretion of this product in breast milk or its effects on breastfed infants. However, it is important to note that the product may cause allergic reactions in some individuals. Therefore, healthcare professionals should exercise caution and consider the potential risks when advising lactating mothers about the use of this product.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. This may include monitoring vital signs, providing respiratory support, and administering intravenous fluids if indicated.

Additionally, healthcare professionals should consider contacting a poison control center for guidance on specific management protocols tailored to the substance involved in the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

This product is contraindicated for use during pregnancy due to potential non-teratogenic effects. Additionally, it may cause allergic reactions in some individuals.

Postmarketing Experience

Postmarketing experience has identified the potential for allergic reactions in some individuals following the use of this product. These events have been reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to consult their doctor if symptoms persist for more than 7 days or if symptoms clear up and then recur within a few days. Additionally, healthcare providers should emphasize the importance of monitoring for any adverse reactions, such as rash, itching, or excessive skin irritation, and to report these symptoms promptly.

It is also crucial to inform patients that if their condition worsens or does not improve after regular use of the medication, they should seek medical advice. This guidance will help ensure safe and effective use of the medication.

Storage and Handling

The product is supplied in a package that should be stored in a cool, dry place, away from direct sunlight to maintain its integrity. After opening, it is essential to re-seal the package to ensure optimal preservation of the product.

Additional Clinical Information

The medication is administered topically, with a recommended application to the affected area not exceeding three times daily. Clinicians should advise patients to avoid contact with eyes, mucous membranes, or rashes, and to refrain from applying the medication to broken, wounded, or damaged skin. It is important not to bandage or cover the treated area with any type of wrap, except for clothing, and to avoid using the medication in conjunction with a heating pad or applying external heat.

Patients should be counseled to discontinue use at least one hour prior to bathing or showering and to avoid application immediately after such activities. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center without delay.

Drug Information (PDF)

This file contains official product information for Doctorrelief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)